Amanote Research
Register
Sign In
miRNA-34c-5p Inhibits Amphiregulin-Induced Ovarian Cancer Stemness and Drug Resistance via Downregulation of the AREG-EGFR-ERK Pathway
Oncogenesis
- United States
doi 10.1038/oncsis.2017.25
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Molecular Biology
Date
May 1, 2017
Authors
S-L Tung
W-C Huang
F-C Hsu
Z-P Yang
T-H Jang
J-W Chang
C-M Chuang
C-R Lai
L-H Wang
Publisher
Springer Science and Business Media LLC
Related search
Downregulation of MYPT1 Increases Tumor Resistance in Ovarian Cancer by Targeting the Hippo Pathway and Increasing the Stemness
Molecular Cancer
Cancer Research
Oncology
Molecular Medicine
Small Molecule Inhibitors of the Host Cell COX/AREG/EGFR/ERK Pathway Attenuate Cytomegalovirus-Induced Pathogenesis
Experimental and Molecular Pathology
Forensic Medicine
Pathology
Clinical Biochemistry
Molecular Biology
Downregulation of Vimentin Expression Increased Drug Resistance in Ovarian Cancer Cells
Oncotarget
Oncology
Loss of MED12 Induces Tumor Dormancy in Human Epithelial Ovarian Cancer via Downregulation of EGFR
Cancer Research
Cancer Research
Oncology
EMT-Induced Stemness and Tumorigenicity Are Fueled by the EGFR/Ras Pathway
PLoS ONE
Multidisciplinary
Taurine Inhibits Serum Deprivation-Induced Osteoblast Apoptosis via the Taurine Transporter/Erk Signaling Pathway
Brazilian Journal of Medical and Biological Research
Downregulation of miR-194-5p Induces Paclitaxel Resistance in Ovarian Cancer Cells by Altering MDM2 Expression
Oncotarget
Oncology
Cyclovirobuxine D Inhibits Colorectal Cancer Tumorigenesis via the CTHRC1‑AKT/ERK‑Snail Signaling Pathway
International Journal of Oncology
Cancer Research
Oncology
Integrins and Cancer: Regulators of Cancer Stemness, Metastasis, and Drug Resistance
Trends in Cell Biology
Cell Biology
